{"id":"https://openalex.org/W9311926","doi":null,"title":"Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.","display_name":"Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W9311926","mag":"9311926","pmid":"https://pubmed.ncbi.nlm.nih.gov/15700745"},"language":"en","primary_location":{"id":"pmid:15700745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15700745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053928888","display_name":"Efstathios Andreas Rallis","orcid":"https://orcid.org/0000-0001-8806-281X","observed_orcids":["https://orcid.org/0000-0001-8806-281X"]},"institutions":[{"id":"https://openalex.org/I4210106119","display_name":"NIMTS Hospital","ror":"https://ror.org/00y1kmp77","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210106119"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"E Rallis","raw_affiliation_strings":["Department of Dermatology, NIMTS Hospital of Athens, Athens, Greece. efrall@otenet.gr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, NIMTS Hospital of Athens, Athens, Greece. efrall@otenet.gr","institution_ids":["https://openalex.org/I4210106119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002113869","display_name":"A Nasiopoulou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Nasiopoulou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113728659","display_name":"CONSTANTINE E. KOUSKOUKIS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Kouskoukis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086166873","display_name":"Elma Koumantaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Koumantaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4895,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.93760109,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"30","issue":"5-6","first_page":"191","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pimecrolimus","display_name":"pimecrolimus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/seborrheic-dermatitis","display_name":"seborrheic dermatitis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/topical-corticosteroid-alternatives","display_name":"topical corticosteroid alternatives","score":0.7639999985694885},{"id":"https://openalex.org/keywords/cytokine-inhibitors","display_name":"cytokine inhibitors","score":0.6110000014305115},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.9190000295639038}],"concepts":[{"id":"https://openalex.org/C2776028589","wikidata":"https://www.wikidata.org/wiki/Q417489","display_name":"Pimecrolimus","level":4,"score":0.9528777599334717},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9424705505371094},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8652065992355347},{"id":"https://openalex.org/C2777484424","wikidata":"https://www.wikidata.org/wiki/Q448310","display_name":"Seborrheic dermatitis","level":2,"score":0.8214161396026611},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.6468023061752319},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5993985533714294},{"id":"https://openalex.org/C3020110884","wikidata":"https://www.wikidata.org/wiki/Q695416","display_name":"Outpatient clinic","level":2,"score":0.49257904291152954},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4323940873146057},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34777504205703735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34038496017456055},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.22165295481681824},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.07520276308059692}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005145","descriptor_name":"Face","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009823","descriptor_name":"Ointment Bases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012628","descriptor_name":"Dermatitis, Seborrheic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012628","descriptor_name":"Dermatitis, Seborrheic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15700745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15700745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Clinical Trial"},{"id":"mag:9311926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15700745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W1512923626","https://openalex.org/W1782902465","https://openalex.org/W1939041013","https://openalex.org/W1965679449","https://openalex.org/W1967566314","https://openalex.org/W1969779239","https://openalex.org/W1970367888","https://openalex.org/W1977247384","https://openalex.org/W1977382144","https://openalex.org/W1981891173","https://openalex.org/W1985530497","https://openalex.org/W1991666427","https://openalex.org/W1996108093","https://openalex.org/W1996940755","https://openalex.org/W2000363595","https://openalex.org/W2001865657","https://openalex.org/W2005111389","https://openalex.org/W2005559533","https://openalex.org/W2005624612","https://openalex.org/W2005897842","https://openalex.org/W2009243814","https://openalex.org/W2012514513","https://openalex.org/W2017901088","https://openalex.org/W2018330782","https://openalex.org/W2021178076","https://openalex.org/W2045284958","https://openalex.org/W2051746492","https://openalex.org/W2053899378","https://openalex.org/W2055207238","https://openalex.org/W2055891072","https://openalex.org/W2059024518","https://openalex.org/W2059887053","https://openalex.org/W2059938655","https://openalex.org/W2060509660","https://openalex.org/W2061161259","https://openalex.org/W2061344417","https://openalex.org/W2062489497","https://openalex.org/W2066746641","https://openalex.org/W2072207295","https://openalex.org/W2077707065","https://openalex.org/W2081634403","https://openalex.org/W2084793623","https://openalex.org/W2086092458","https://openalex.org/W2087086840","https://openalex.org/W2087389654","https://openalex.org/W2093757762","https://openalex.org/W2094614798","https://openalex.org/W2104538950","https://openalex.org/W2108849121","https://openalex.org/W2111666128","https://openalex.org/W2121483776","https://openalex.org/W2124997151","https://openalex.org/W2125837141","https://openalex.org/W2134141712","https://openalex.org/W2135768739","https://openalex.org/W2142819637","https://openalex.org/W2153641000","https://openalex.org/W2176056137","https://openalex.org/W2230876051","https://openalex.org/W4245933202","https://openalex.org/W4319688303","https://openalex.org/W6601937592"],"related_works":["https://openalex.org/W2020836991","https://openalex.org/W2375125748","https://openalex.org/W2037537994","https://openalex.org/W2223977959","https://openalex.org/W2156378911","https://openalex.org/W2466805719","https://openalex.org/W2141309750","https://openalex.org/W2150540084","https://openalex.org/W4289519900","https://openalex.org/W2069316711"],"abstract_inverted_index":{"The":[0,143],"ascomycin":[1],"macrolactam":[2],"derivative":[3],"pimecrolimus":[4,34,273],"is":[5],"a":[6,112,174,188,279],"novel,":[7],"nonsteroidal,":[8],"cell-selective":[9],"inhibitor":[10],"of":[11,19,33,40,47,67,70,97,110,146,167,196,202,219,228,241,256,287],"inflammatory":[12,20],"cytokines":[13],"specifically":[14],"developed":[15],"for":[16,89,93,180],"the":[17,28,38,48,63,68,197,217,226,239,242,257,285,296],"treatment":[18,39,286],"skin":[21,258],"diseases.":[22],"Our":[23],"objective":[24],"was":[25,83,106,115,149,248,266],"to":[26,59,178,192,294],"assess":[27],"efficacy,":[29,198],"tolerability":[30,201],"and":[31,50,92,120,132,141,160,170,200,224,235,254,281,298],"safety":[32,199],"cream":[35,81],"1%":[36,82],"in":[37,74,165,194,213,259,284],"seborrheic":[41,45,147,288],"dermatitis.":[42,289],"Adults":[43],"with":[44],"dermatitis":[46,148],"face":[49],"upper":[51],"trunk":[52],"who":[53],"were":[54,72,126,211,231],"seen":[55],"from":[56,176,190,251],"October":[57],"2003":[58],"April":[60],"2004":[61],"at":[62,128,133,136],"Dermatologic":[64],"Outpatient":[65],"Clinic":[66],"University":[69],"Thrace":[71],"enrolled":[73,212],"this":[75,214],"9-week":[76],"open-label":[77],"uncontrolled":[78],"study.":[79,215],"Pimecrolimus":[80],"applied":[84,274],"as":[85,151],"monotherapy":[86],"twice":[87,275],"daily":[88,276],"7":[90,98],"days":[91,99],"an":[94,121],"additional":[95],"period":[96],"thereafter,":[100],"if":[101],"needed,":[102],"until":[103],"complete":[104,229],"clearance":[105,230],"achieved.":[107],"In":[108],"cases":[109],"recurrence":[111],"5-day":[113],"course":[114],"additionally":[116],"applied.":[117],"After":[118],"screening":[119],"appropriate":[122],"washout":[123],"period,":[124],"subjects":[125],"evaluated":[127],"baseline":[129],"(day":[130],"0)":[131],"follow-up":[134],"visits":[135],"weeks":[137,220],"1,":[138,221],"3,":[139,222],"6":[140,223],"9.":[142],"clinical":[144],"severity":[145],"estimated":[150],"mild":[152],"(total":[153,157,162],"score":[154,158,163,247],"1-3),":[155],"moderate":[156],"4-6)":[159],"severe":[161],"7-9)":[164],"terms":[166,195],"erythema,":[168],"scaling":[169],"lesional":[171],"extent":[172],"using":[173],"scale":[175,189],"0":[177,191],"3":[179],"each.":[181],"Patients":[182],"also":[183],"assessed":[184],"their":[185],"symptoms":[186],"on":[187],"5":[193],"topical":[203,252],"application.":[204],"Nineteen":[205],"patients":[206],"(12":[207],"males,":[208],"seven":[209],"females)":[210],"At":[216,238],"end":[218,240],"9":[225],"percentages":[227],"63%,":[232],"100%,":[233],"47%":[234],"52%,":[236],"respectively.":[237],"study,":[243],"subjects'":[244],"average":[245],"assessment":[246],"9.73.":[249],"Apart":[250],"burning":[253],"irritation":[255],"four":[260],"patients,":[261],"no":[262],"other":[263],"adverse":[264],"event":[265],"mentioned.":[267],"This":[268],"pilot":[269],"study":[270],"indicates":[271],"that":[272],"can":[277],"be":[278],"safe":[280],"efficacious":[282],"alternative":[283],"Further":[290],"studies":[291],"are":[292],"needed":[293],"determine":[295],"initial":[297],"maintenance":[299],"therapy.":[300]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}